skip navigation links
National Center for Complementary and
Alternative Medicine (NCCAM)
National Insitutes of Health
Text size  A A Contact Us Site Map
       
Home  Health Information Research  Training  Clinical Trials  News and Events  About NCCAM

Back to: Research : Funding Announcements

Requests for Applications


On this page:

Notices

  • 07/14/03
    Plans to develop an RFA to continue the NIH Botanical Research Centers Program.

Active Requests for Applications

  • The Use of Complementary and Alternative Medicine (CAM) in the Management of HIV/AIDS
    RFA: AT-05-004
    Letter of Intent Receipt Date: 12/14/04
    Receipt Date: 01/14/05

    The objectives of this solicitation are to (1) identify potential roles for CAM therapies in managing HIV/AIDS and/or its complications; (2) understand mechanisms of action of CAM interventions that have the potential for contributing to or interfering with standard treatments for HIV/AIDS and related conditions; and (3) stimulate CAM research at leading HIV/AIDS research institutions.

  • Prevention and Treatment of Childhood Obesity in Primary Care Settings
    RFA: HD-04-020
    Letter of Intent Receipt Date: 10/25/04
    Receipt Date: 11/23/04
    Research projects would test intervention programs delivered in primary care practices to improve dietary and physical activity behaviors of pediatric patients.

  • NIH Roadmap Initiatives
    Several grants and funding opportunities have been developed through the NIH Roadmap Initiatives.

  • Ancillary Studies to Obesity-Related Clinical Trials
    RFA: DK-03-022
    Letter of Intent Receipt Date: 2/19/04, 10/19/04, 6/17/05
    Receipt Date: 3/19/04, 11/19/04, 7/19/05
    The goal of this initiative is to solicit research grant applications for ancillary studies investigating obesity-related research questions in conjunction with six cooperative agreement clinical trials and consortia sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and one cooperative agreement sponsored by the National Insitute on Aging (NIA). These ancillary study proposals may utilize patients and/or patient materials from the seven clinical cooperative agreements cited in the RFA, subject to study-specific restrictions. The NCCAM is interested in supporting investigations of complementary or alternative approaches to weight maintenance and the prevention and treatment of overweight or obesity.

  • Clinical Research Curriculum Award
    RFA: HL-04-004
    Letter of Intent Receipt Date: 12/16/03
    Receipt Date: 1/16/04
    NIH invites educational and research institutions to apply for this program, which addresses, in part, the NIH's commitment to improve the quality of training in clinical research. The initial and competing renewal awards will be for five years each.



  • Top

    Past Requests for Applications

    • Research on Mind-Body Interactions and Health
      RFA: OD-03-008
      Letter of Intent Receipt Date: 11/17/03
      Receipt Date: 12/17/03
      The NIH invites applications in support of research on mind-body interactions and health. "Mind-body interactions and health" refers to the relationships among cognitions, emotions, personality, social relationships, and health.

    • Dietary Supplement Research Centers: Botanicals
      RFA: OD-04-002
      Letter of Intent Receipt Date: 5/18/04
      Receipt Date: 6/15/04
      The goal of this initiative is to support research centers of excellence which will (1) promote interdisciplinary collaborative study of botanicals, particularly those that are found as ingredients in dietary supplements and (2) conduct research of high potential for being translated into practical benefits for human health.

    • Mind-body Interactions and Health: Exploratory/Developmental Research Program (R21)
      RFA: OB-03-005
      Letter of Intent Receipt Date: 06/16/03
      Receipt Date: 07/16/03
      The National Institutes of Health (NIH) invite applications for infrastructure grants in support of research on mind-body interactions and health. "Mind-body interactions and health" refers to the relationships among cognitions, emotions, personality, social relationships, and health. Exploratory/Developmental Awards are intended to support the development and demonstrate the feasibility of programs at institutions that have high potential for advancing mind-body and health research, but have not yet fully achieved the necessary resources and mechanisms to qualify for a R24 Research Infrastructure Award.

    • Mind-body Interactions and Health: Research Infrastructure Program (R24)
      RFA: OB-03-004
      Letter of Intent Receipt Date: 06/16/03
      Receipt Date: 07/16/03
      The National Institutes of Health (NIH) invite applications for infrastructure grants in support of research on mind-body interactions and health. "Mind-body interactions and health" refers to the relationships among cognitions, emotions, personality, social relationships, and health.

    • Cranberry: Urinary Tract Infection and Other Conditions
      RFA: AT-03-004
      Letter of Intent Receipt Date: 04/22/03
      Receipt Date: 05/20/03
      The purpose of this initiative is to support basic and clinical research on the role of cranberry (Vaccinium macrocarpon) in the prevention and treatment of urinary tract infections (UTI), other infections, and other conditions for which there is credible evidence of efficacy.

    • Planning Grants for International Centers for Research on Complementary and Alternative Medicine (PICRC)
      RFA: AT-03-002
      Letter of Intent Receipt Date: 02/28/03
      Receipt Date: 03/28/03
      Planning Grants for International Centers will support U.S. and international institutions to jointly plan exploratory and developmental studies of traditional/alternative healing approaches. The Planning Grants will lay the groundwork for developing applications for an International Center for Research on CAM that will be called for in 2004.

    • Complementary and Alternative Medicine (CAM) Therapy in the Treatment of HIV/AIDS
      RFA: AT-03-001
      Letter of Intent Receipt Date: 11/11/02
      Receipt Date: 12/10/02
      This initiative will support research to identify potential roles for the safe and effective use of CAM in the treatment of HIV/AIDS and its complications, or to ameliorate medication side effects. NCCAM and the National Institute of Nursing Research (NINR) are especially interested in supporting well-designed studies to characterize and investigate traditional medicine practices used in the treatment of HIV/AIDS.

    • Human Subjects Research Enhancements Programs
      RFA: OD-02-003
      Letter of Intent Receipt Date: 03/05/02
      Receipt Date: 05/15/02
      The purpose of this initiative is to provide short-term interim support for institutional activities that will strengthen oversight of human subjects research at institutions that receive significant NIH support for clinical research.

    • S-Adenosyl-L-Methionine (SAMe) and Liver Disease
      RFA: AA-02-011
      Letter of Intent Receipt Date: 04/15/02
      Receipt Date: 05/15/02
      The purpose of this RFA is to invite applications for grants proposing innovative basic and preclinical research to understand how SAMe may be effective in the treatment of liver disease caused by alcohol and other factors such as hepatitis C virus (HCV).

    • Alternative Therapies for Benign Prostate Symptoms--Clinical Trials Consortium
      RFA: DK-02-026
      Letter of Intent Receipt Date: 03/15/02
      Receipt Date: 04/15/02
      The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Center for Complementary and Alternative Medicine (NCCAM), and the Office of Dietary Supplements (ODS) invite cooperative agreement grant applications to establish a research consortium to conduct a randomized controlled clinical trial of Serenoa repens (Saw palmetto) and Pygeum africanum in men with benign prostatic hyperplasia (BPH).

    • Bioterrorism-Related Research
      RFA: NOT-AI-02-003
      Letter of Intent Receipt Date: 01/15/02
      Receipt Date: 02/15/02
      NCCAM is interested in applications for innovative research targeted at testing complementary and alternative medicine therapeutic or preventive agents for pathogens that might conceivably be vehicles for biological warfare activities.

    • Botanical/Drug Interactions in HIV
      RFA: AT-02-003
      Letter of Intent Receipt Date: 02/28/02
      Receipt Date: 03/28/02
      This initiative will support research into interactions between botanical substances and prescription drugs used in the treatment of human immunodeficiency virus (HIV) infection and its complications.

    • Elucidation of the Underlying Mechanisms of Placebo Effect
      RFA: AT-02-002
      Letter of Intent Receipt Date: 03/01/00
      Receipt Date: 04/11/02
      The goal of this initiative is to stimulate integrative research aimed at delineating the underlying mechanisms by which a placebo leads to its ultimate physiological and psychological effects.



    • The Placebo Effect in Clinical Practice
      RFA: AT-02-001
      Letter of Intent Receipt Date: 03/01/02
      Receipt Date: 04/11/02
      The proposed initiative is expected to stimulate investigator-initiated research investigations on how placebos and placebo effects impact on clinical practice. An important goal is to understand what factors are necessary to elicit a placebo effect in clinical practice so that the benefits of the therapeutic intervention can be enhanced to improve health and promote wellness.



    • EDTA Chelation Therapy for Coronary Artery Disease
      RFA: AT-01-004
      Letter of Intent Receipt Date: 07/18/01
      Receipt Date: 08/29/01
      The purpose of this RFA is to invite applications for a multi-site, randomized, double-blinded, placebo-controlled trial investigating the efficacy and safety of EDTA (ethylene diamine tetra-acetic acid) chelation therapy in individuals suffering from Coronary Artery Disease (CAD).

    • NCCAM Institutional Research Training Program (T32) for Minority Researchers
      RFA: AT-01-003
      Letter of Intent Receipt Date: 04/16/01
      Receipt Date: 05/14/01
      This Ruth L. Kirschstein National Research Service Award (NRSA) RFA will fund research training at minority and minority-serving institutions for individuals who are training for careers in biomedical, behavioral, and clinical research related to complementary and alternative medicine (CAM).

    • Complementary/Alternative Medicine (CAM) at the End of Life for Cancer and/or HIV/AIDS
      RFA: AT-01-002
      Letter of Intent Receipt Date: 02/26/01
      Receipt Date: 04/12/01
      The primary objective of this initiative is to identify and evaluate CAM interventions for patients with advanced, terminal disease associated with cancer or HIV/AIDS. This research is expected to generate scientific knowledge on complementary and alternative medicine (CAM) therapies that will ultimately lead to improved care and quality of life for individuals at the end of life.

      Possible patient outcomes would include:
      1. Managing or reducing the symptoms associated with the conditions of end stage disease for cancer and HIV/AIDS;
      2. Preventing or reducing side effects of medications such as antiretrovirals, steroids, and chemotherapy/radiotherapy; and
      3. Enhancing the psychological, social, spiritual well-being, and quality of life at the end of life.

    • Integration of Complementary and Alternative Medicine: A Health Services Research Perspective
      RFA: AT-01-001
      Letter of Intent Receipt Date: 12/08/00
      Receipt Date: 01/24/01
      The intent of this RFA is to 1) identify barriers and facilitators to the integration of CAM and conventional health care practices; 2) determine whether CAM research results obtained from studies conducted under ideal conditions (efficacy studies) can be translated to real-world settings (i.e., effectiveness) within an integrated model; and 3) support the evaluation of currently planned or recently initiated programs, goals of which are to improve the outcomes, quality, effectiveness, and/or cost-effectiveness of health care through the integration of CAM and conventional health care.

    • Botanical Drug Interactions
      RFA: AT-00-004
      Letter of Intent Receipt Date: 11/10/00
      Receipt Date: 01/12/01
      The main objective of this initiative is to encourage biomedical research in order to prevent adverse botanical/drug interactions during therapy or anesthesia, to establish possible synergistic combinations of botanicals with pharmaceutical drugs, and to increase our knowledge of the mechanisms of action of botanicals.

    • Exploratory Program Grants for Frontier Medicine Research
      RFA: AT-00-002
      Letter of Intent Receipt Date: 08/07/00
      Receipt Date: 11/14/00
      This NCCAM initiative will establish Exploratory Program Grants for Frontier Medicine Research, the purpose of which will be to create an infrastructure to nurture and therefore advance this field of biomedical research by providing the institutional support and resources necessary for rigorous scientific investigation.

    • Botanical Products Development: SBIR and STTR
      RFA: AT-00-003
      Letter of Intent Receipt Date: 09/07/00
      Receipt Date: 11/14/00
      The purpose of this Request for Applications (RFA) is to support projects that could lead to development of appropriate standardized products (valerian root, feverfew, echinacea, and milk thistle) and provision of a reliable constant supply of these products for clinical research, as well as basic research.

    • Global Network for Women's and Children's Health Research
      RFA: HD-00-007
      Letter of Intent Receipt Date: 04/14/00
      Receipt Date: 07/13/00
      The purpose of this solicitation is to establish an innovative and flexible research network that will be responsive to the most critical existing and emerging health needs and public health problems of women and children, globally.

    • Centers for Dietary Supplement Research: Botanicals
      RFA: OD-00-004
      Letter of Intent Receipt Date: 03/25/00
      Receipt Date: 04/25/00
      The Office of Dietary Supplements (ODS) and the NCCAM invite grant proposals to establish Specialized Research Centers to investigate the biological effects of botanicals including, but not limited to, botanicals available as dietary supplements. The creation of such Centers is needed to advance the quality and quantity of scientific information on botanicals and to promote further research in this area.

    • Centers for Complementary and Alternative Medicine Research
      RFA: AT-00-001
      Letter of Intent Receipt Date: 01/07/00
      Receipt Date: 03/14/00
      The National Center for Complementary and Alternative Medicine (NCCAM), the National Cancer Institute (NCI), and the National Heart, Lung, and Blood Institute (NHLBI) invite applications for Centers for CAM Research using the P50 Specialized Center grant mechanism. Such Centers will provide the resources necessary for the rigorous scientific investigation of CAM. It is expected that research conducted at these Centers will examine the potential efficacy, effectiveness, safety, and validity of CAM practices, as well as the physiological or psychological mechanisms underlying or contributing to the effects of these practices. Applicants should propose a multidiscliplinary research focus that incorporates basic and clinical research with either an asthma or cancer theme.

    • Ginkgo Biloba Prevention Trial in Older Individuals
      RFA: AT-99-001
      Letter of Intent Receipt Date: 04/21/99
      Receipt Date: 05/21/99
      The National Center for Complementary and Alternative Medicine (NCCAM) and the National Institute on Aging (NIA) invite applications for a two-arm, double-blind, randomized, placebo-controlled multi-site trial to assess whether an extract of the botanical product, Ginkgo biloba, prevents the occurrence of dementia and/or cognitive decline in older individuals.

    • Research on Care at the End of Life
      RFA: NR-99-004
      Letter of Intent Receipt Date: 04/30/99
      Receipt Date: 05/21/99
      The purpose of this initiative is to generate research that will improve the quality of dying for Americans and decrease the distress for their caregivers. Research applications may include basic, clinical, or health care studies focused on the clinical management of physical and psychological symptoms, patient-provider and patient-family communication, ethics and clinical decision-making, caregiver support, or the context of care delivery for those facing life-limiting illnesses.

    • Centers for Complementary and Alternative Medicine Research
      RFA: OD-98-008
      Letter of Intent Receipt Date: 12/11/98
      Receipt Date: 01/22/99
      Applications are being sought for Centers for CAM Research using the Specialized Center (P50) grant mechanism. Such Centers will provide resources necessary for the rigorous scientific investigation of CAM. It is expected that research conducted at these Centers will examine the efficacy, effectiveness, safety, and validity of CAM practices, as well as the physiological or psychological mechanisms underlying these practices.

    • Specialized Centers of Research (SCORS) in Ischemic Heart Disease in Blacks
      RFA: HL-98-015
      Letter of Intent Receipt Date: 05/07/99
      Receipt Date: 09/15/99
      Interdisciplinary study of issues surrounding the expression of heart disease in Blacks. Applicants should select one of the following three themes: Sudden Cardiac Death; Microvascular Disease; Diabetic Heart Disease.

    • Specialized Centers of Research in Ischemic Heart Disease
      RFA: HL-98-007
      Letter of Intent Receipt Date: 06/12/98
      Receipt Date: 12/29/98
      Interdisciplinary approaches to the elucidation of the etiology and pathophysiology of ischemic heart disease, sudden cardiac death, and heart failure at the molecular, cellular, and tissue levels.

    • Basic and Clinical Research on Fibromyalgia
      RFA: AR-98-006
      Letter of Intent Receipt Date: 05/15/98
      Receipt Date: 07/15/98
      Research studies related to all aspects of pathogenesis and clinical manifestations of fibromyalgia syndrome (FMS) and to relationships between FMS and temporomandibular disorders (TMDs).

    • Innovative Approaches to Disease Prevention Through
      Behavior Change

      RFA: OD-98-002
      Letter of Intent Receipt Date: 04/01/98
      Receipt Date: 05/21/98
      A four-year research grant program to test interventions designed to achieve long-term health behavior change.

    • Centers for Complementary and Alternative Medicine Research
      RFA: OD-98-003 ERRATA
      Letter of Intent Receipt Date: N/A
      Receipt Date: 01/13/98
      A correction issued for RFA OD-98-003, which was published in the NIH GUIDE, Volume 26, Number 34, October 10, 1997.

    • Centers for Complementary and Alternative Medicine Research
      RFA: OD-98-003
      Letter of Intent Receipt Date: 12/01/97
      Receipt Date: 01/13/98
      The OAM, NICHD, and NIDA seek to encourage research of CAM by establishing CAM Centers of Research, which will make the resources necessary for the conduct of high quality research available to investigators interested in CAM.

    • Acupuncture Treatment for Osteoarthritis
      RFA: OD-97-006
      Letter of Intent Receipt Date: 08/17/97
      Receipt Date: 09/19/97
      The OAM and NIAMS seek to initiate a clinical trial of acupuncture for the treatment of osteoarthritis (OA) of the knee. See correction or ERRATA issued on August 1, 1997.

    • Center for Chiropractic Research
      RFA: OD-97-005
      Letter of Intent Receipt Date: 04/09/97
      Receipt Date: 05/09/97
      Seeks to encourage research of chiropractic by establishing a Center for Chiropractic Research, which will make the resources necessary for the conduct of high quality research available to investigators interested in chiropractic.

    Top

    Related Topics
    bullet NIH Guide for Grants and Contracts for all published RFPs, RFAs, and PAs.

     
     NIH logo    H H S logo - link to U. S. Department of Health and Human Services    FirstGov logo